Enanta Pharmaceuticals
ENTA
#7360
Rank
C$0.61 B
Marketcap
C$21.24
Share price
5.92%
Change (1 day)
151.65%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.29 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30C$0.33 B0.47%
2023-09-30C$0.33 B347.87%
2022-09-30C$74.5 M49.24%
2021-09-30C$49.92 M22.82%
2020-09-30C$40.65 M12.29%
2019-09-30C$36.19 M37.2%
2018-09-30C$26.38 M-14.79%
2017-09-30C$30.96 M107.42%
2016-09-30C$14.92 M13.73%
2015-09-30C$13.12 M73.24%
2014-09-30C$7.57 M12.82%
2013-09-30C$6.71 M-17.12%
2012-09-30C$8.1 M88.72%
2011-09-30C$4.29 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
C$188.37 B 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.69 B 52,460.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$10.41 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$107.14 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.04 B 36,142.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$86.30 B 28,850.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland